Maria Palasis Lyra Therapeutics, Inc. (LYRA) insider trading activity
Maria Palasis is President & CEO of Lyra Therapeutics, Inc.. Currently has a direct ownership of 300,000 shares of LYRA, which is worth approximately $54,000. The most recent transaction as insider was on Oct 16, 2024, when has been sold 300,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
300K
n/a
3M change
n/a
12M change
Total Value Held
$54,000
MP
Maria Palasis
President & CEO
Watertown, MA